(HealthDay)—Prescribers of extended-release/long-acting (ER/LA) opioid analgesics are encouraged to participate in continuing medical education (CME) provided by manufacturers of these analgesics, according ...
Medications Mar 12, 2013 | not rated yet | 0
(AP)—Diners will have to wait a little longer to find calorie counts on most restaurant chain menus, in supermarkets and on vending machines.
Health Mar 12, 2013 | not rated yet | 0
The U.S. Justice Department is investigating drug maker Sanofi's disclosures to the Food and Drug Administration about different responses to its blockbuster blood thinner Plavix.
Medications Mar 11, 2013 | not rated yet | 0
The pharmaceutical industry has pulled back on marketing to physicians and consumers, yet some enduring patterns persist. According to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health, ...
Medications Mar 04, 2013 | not rated yet | 0 |
Food and Drug Administration Commissioner Margaret Hamburg says the lack of a new 2013 budget from Congress and the upcoming across-the-board spending cuts will mean fewer food safety inspections and an increased ...
Health Feb 28, 2013 | not rated yet | 0
(HealthDay)—If you're thinking about getting breast implants, there are some things you need to know before you make your decision, according to the U.S. Food and Drug Administration.
Other Feb 27, 2013 | 2.5 / 5 (2) | 1
The U.S. Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones.
Cancer Feb 22, 2013 | 5 / 5 (1) | 0
(HealthDay)—The Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Gel Filled Breast Implant has been approved by the U.S. Food and Drug Administration for breast augmentation in women aged 22 years ...
Other Feb 21, 2013 | not rated yet | 0
(HealthDay)—Pomalyst (pomalidomide) has been approved by the U.S. Food and Drug Administration to treat cases of multiple myeloma that have not responded to other therapies.
Medications Feb 09, 2013 | not rated yet | 0
A University of Colorado Cancer Center review published this week in the journal Lancet Oncology describes possible long-term side-effects of new, targeted therapies in pediatric cancer patients: what we don't know may hu ...
Cancer Feb 07, 2013 | not rated yet | 0
The Food and Drug Administration is warning U.S. doctors about another counterfeit version of the cancer drug Avastin, the third case involving the best-selling Roche drug in the past year.
Medications Feb 06, 2013 | 5 / 5 (1) | 0
Spectator sports and food—often high-calorie or low-nutrition—have long gone hand-in-hand, yet FDA regulations geared toward calorie transparency at restaurant chains ignore this relationship. Popular fast-food restaurants ...
Health Feb 05, 2013 | not rated yet | 0
(HealthDay)—The first generic version of the cancer drug Doxil (doxorubicin hydrochloride liposome injection) has been approved by the U.S. Food and Drug Administration, which says the action should help relieve shortages ...
Medications Feb 04, 2013 | not rated yet | 0
(HealthDay)—Ravicti (glycerol phenylbutyrate) has been approved by the U.S. Food and Drug Administration to treat certain urea cycle disorders (UCDs) in people 2 years and older.
Medications Feb 01, 2013 | not rated yet | 0
A multi-center study supports the effectiveness of the newest technology available for the treatment of difficult, life-threatening brain aneurysms. The technology, the Pipeline embolization device, is a flow diverter that ...
Neuroscience Jan 30, 2013 | not rated yet | 0